Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-042877

Director acquired 8,217 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kazam Joshua A Director 2019-07-18 Other acquisition +8,217 1,420,835 D
Loading xslF345X03/doc4.xml…